BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 283276)

  • 1. A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens.
    McCabe RP; Quaranta V; Frugis L; Ferrone S; Reisfeld RA
    J Natl Cancer Inst; 1979 Mar; 62(3):455-63. PubMed ID: 283276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.
    Imai K; Ferrone S
    Cancer Res; 1980 Jul; 40(7):2252-6. PubMed ID: 6966965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human melanoma associated antigens: a solid-phase assay for detection of specific antibody.
    Morgan AC; Galloway DR; Wilson BS; Reisfeld RA
    J Immunol Methods; 1980; 39(3):233-46. PubMed ID: 7462650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-A antibody-binding TPAAB) technique for detection of tumor-associated membrane antigen (TAMA) of Lewis lung carcinoma.
    Veltri RW; McKolanis JR; Rockoff SD; McIntire KR
    Int J Cancer; 1980 Jan; 25(1):141-5. PubMed ID: 7399741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.
    Galloway DR; McCabe RP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1981 Jan; 126(1):62-6. PubMed ID: 7451981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of tumour associated antigen in eluates from protein A columns used for ex vivo immunoadsorption of plasma from melanoma patients by radioimmunoassay.
    Gupta RK; Leitch AM; Morton DL
    Clin Exp Immunol; 1983 Sep; 53(3):589-99. PubMed ID: 6193912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature of antigens and antibodies in immune complexes isolated by staphylococcal protein A from plasma of melanoma patients.
    Gupta RK; Leitch AM; Morton DL
    Cancer Immunol Immunother; 1983; 16(1):40-7. PubMed ID: 6556950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of heteroantisera to cells from human malignant effusions by immunofluorescence and protein A binding.
    Birchall JP; Owen JJ; Owen BS
    Br J Cancer; 1977 Dec; 36(6):730-42. PubMed ID: 339939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association of serologically detectable human melanoma-associated antigens with beta 2 microglobulin: serologic and immunochemical evidence.
    McCabe RP; Indiveri F; Galloway DR; Ferrone S; Reisfeld RA
    J Natl Cancer Inst; 1980 Oct; 65(4):703-7. PubMed ID: 6158590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification and immunologic evaluation of human melnoma-associated antigens.
    McCabe RP; Ferrone S; Pellegrino MA; Kern DH; Holmes EC; Reisfeld RA
    J Natl Cancer Inst; 1978 Apr; 60(4):773-7. PubMed ID: 75978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE; Mann BD; Morton DL; Burk MW
    Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera.
    Wilson BS; Kay NE; Imai K; Ferrone S
    Cancer Immunol Immunother; 1982; 13(1):69-74. PubMed ID: 7159874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
    Houghton AN; Taormina MC; Ikeda H; Watanabe T; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4260-4. PubMed ID: 6933476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microassay using radioiodinated protein A from Staphylococcus aureus for antibodies bound to cell surface antigens of adherent tumor cells.
    Zeltzer PM; Seeger RC
    J Immunol Methods; 1977; 17(1-2):163-75. PubMed ID: 903615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of DR xenoantisera: use for detection of serum DR antigens.
    Wilson BS; Indiveri F; Pellegrino MA; Ferrone S
    J Immunol; 1979 May; 122(5):1967-71. PubMed ID: 376728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of antisera with specificity for malignant melanoma and human fetal skin.
    Fritze D; Kern DH; Drogemuller CR; Pilch YH
    Cancer Res; 1976 Feb; 36(2 Pt 1):458-66. PubMed ID: 56991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of humoral and cell-mediated immunity in human melanoma.
    Mukherji B; Nathanson L; Clark DA
    Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunofluorescent studies of the serologic reactivity of patients with malignant melanoma against tumor-associated cytoplasmic antigens.
    Wood GW; Barth RF
    J Natl Cancer Inst; 1974 Aug; 53(2):309-16. PubMed ID: 4602060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.